The American Journal of Surgery
Volume 199, Issue 4 , Pages 515-521 , April 2010

Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro

  • Li Zhou, M.D.

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
  • ,
  • Xiao-Dong He, M.D.

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
  • ,
  • Jian-Chun Yu, M.D.

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
    • Corresponding Author InformationCorresponding author: Tel.: 86-10-65296038; fax: 86-10-65296038
  • ,
  • Rou-Li Zhou, M.D.

      Affiliations

    • Department of Cell Biology, School of Basic Medical Sciences, Peking University, Beijing, China
  • ,
  • Hua Yang, Ph.D.

      Affiliations

    • Department of Cell Biology, School of Basic Medical Sciences, Peking University, Beijing, China
  • ,
  • Qiang Qu, M.D., Ph.D.

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
  • ,
  • Jing-An Rui, M.D.

      Affiliations

    • Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China

Received 30 January 2009 ,Revised 16 March 2009

References 

  1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  2. Lebofsky R, Walter JC. New Myc-anisms for DNA replication and tumorigenesis?. Cancer Cell. 2007;12:102–103
  3. Shields JM, Pruitt K, McFall A, et al. Understanding Ras: “it ain't over 'til it's over.”. Trends Cell Biol. 2000;10:147–154
  4. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer. 2005;41:2449–2461
  5. Musgrove EA. Cyclins: roles in mitogenic signaling and oncogenic transformation. Growth Factors. 2006;24:13–19
  6. Bourdon JC. p53 and its isoforms in cancer. Br J Cancer. 2007;97:277–282
  7. Liu J, Zhou R, Zhang N, et al. Biological function of a novel gene overexpressed in human hepatocellular carcinoma. Chin Med J. 2000;113:881–885
  8. Shao GZ, Zhou RL, Zhang QY, et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogene. 2003;22:5060–5069
  9. Liu XR, Zhou RL, Zhang QY, et al. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma. World J Gastroenterol. 2004;10:1555–1559
  10. Peng C, Zhou RL, Shao GZ, et al. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. World J Gastroenterol. 2005;11:2704–2708
  11. Kasper G, Vogel A, Klaman I, et al. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett. 2005;224:93–103
  12. Morris DG, Musat M, Czirjak S, et al. Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol. 2005;153:143–151
  13. Zhou L, He XD, Chen J, et al. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. Eur J Cancer. 2007;43:809–815
  14. Zhou L, He XD, Cui QC, et al. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Cancer Lett. 2008;264:209–217
  15. Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder (Results of the French Surgical Association Survey). Ann Surg. 1994;219:275–280
  16. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 1995;75:171–190
  17. Kai M, Chijiiwa K, Ohuchida J, et al. A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma. J Gastrointest Surg. 2007;11:1025–1032
  18. Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol. 2007;96:8–13
  19. Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg. 2007;11:1188–1193
  20. Saetta AA. K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer. J Surg Oncol. 2006;93:644–649
  21. Lynch BC, Lathrop SL, Ye D, et al. Expression of the p16(INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladder. Ann Diagn Pathol. 2008;12:161–164
  22. Hui AM, Li X, Shi YZ, et al. Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin Cancer Res. 2000;6:4272–4277
  23. Miyahara N, Shoda J, Ishige K, et al. MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications. Eur J Cancer. 2008;44:1048–1056
  24. Ye CL, Liu JW, Wei DZ, et al. In vitro anti-tumor activity of 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone against six established human cancer cell lines. Pharmacol Res. 2004;50:505–510
  25. Quan ZW, Yue JN, Li JY, et al. Somatostatin elevates topoisomerase II alpha and enhances the cytotoxic effect of doxorubicin on gallbladder cancer cells. Chemotherapy. 2008;54:431–437
  26. Chang XZ, Wang ZM, Yu JM, et al. Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides. Clin Exp Metastasis. 2007;24:25–38
  27. Chang XZ, Yu J, Zhang XH, et al. Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells. J Cancer Res Clin Oncol. 2009;135:581–590
  28. He J, Shao G, Zhou R. Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells. Beijing Da Xue Xue Bao. 2003;35:348–352
  29. Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res. 2003;283:17–21
  30. Neel BG, Jhanwar SC, Chaganti RS, et al. Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci U S A. 1982;79:7842–7846
  31. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264:436–440
  32. Polyak K, Lee MH, Erdjument-Bromage H, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994;78:59–66

 This work was supported by a grant for the municipal key discipline of Beijing, China (HK100230446).

PII: S0002-9610(09)00509-1

doi: 10.1016/j.amjsurg.2009.03.031

The American Journal of Surgery
Volume 199, Issue 4 , Pages 515-521 , April 2010